glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites P and reacts with Human samples Anti-GLP-1 antibody [11E2]
Pay in 4 interest-free payments of $5.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites P and reacts with Human samples Anti-GLP-1 antibody [11E2]](https://content.abcam.com/products/images/glp-1-antibody-11e2-ab23468--immunocytochemistry-immunofluorescence-img63062.jpg)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites P and reacts with Human samples Anti-GLP-1 antibody [11E2]](https://7tmantibodies.com/media/image/0e/a7/16/GLP1-IHC-F1.png)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites P and reacts with Human samples Anti-GLP-1 antibody [11E2]](https://cdn.antibodies.com/image/catalog/83/A83537_3.jpg?profile=product_top)
![glp-1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites P and reacts with Human samples Anti-GLP-1 antibody [11E2]](https://cdn11.bigcommerce.com/s-jeqpi38dm3/images/stencil/1280x1280/products/1847/882/622-MAB2814-SP__78544__49639.1655907578.jpg?c=1?imbypass=on)



















